Top Ten most popular articles on Pharmafile.com this week
pharmafile | June 16, 2017 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â top tenÂ
The weather is heating up as we head into summer, and another week is behind us, meaning another run-down of the most popular articles on our site over the past seven days.
FlyPharma 2017 took place in Brussels last week, and or summary of the event has proved popular with our readers – be sure to check it out. Another major draw this week was the news that MSD was forced to halt enrolment in clinical trials of its blockbuster drug Keytruda following a number off deaths, dampening the treatment’s otherwise strong showing over the past months.
Unsurprisingly given everyone’s uncertainty over Brexit, readers were drawn particularly to our interview with Marie-Agnes Heine and Juan GarcÃa Burgos of the EMA as they told us what they think will happen to the EU regulator once the UK exits the European Union. And the most popular article this week was Novartis’ discussion on the importance of continuous manufacturing at this time in the industry.
10. Teva conducts boardroom shuffle with four new faces
Teva has sought to begin a new era in leadership by bringing in four new faces to boardroom level.
9. FDA fast-tracks Pfizer and Lilly’s chronic pain drug
Pfizer and Eli Lilly are celebrating the FDA’s decision to grant fast-track designation to their joint venture tanezumab in the treatment of chronic low back pain (CLBP) and pain in osteoarthritis (OA) patients.
8. FlyPharma Conference 2017 – “Collaboration is the key”
The FlyPharma event took place on 6-7 of June, with delegates from airlines mingling with logistics companies, individuals from the pharmaceutical industry and those working in the regulatory industry.
7. AbbVie loses $15 million Depakote birth-defect case
Court cases for the anti-seizure medicine Depakote continue to rumble on for AbbVie, with the latest case finding AbbVie liable to pay $15 million in damages for the care of a boy born with birth defects.
6. New game, new rules: Pathways for better and affordable medicines in Europe
Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest developments in market access across Europe, and the collaborative efforts its constituents are engaging in to improve it.
5. MSD forced to pause enrolment after Keytruda deaths
MSD has been hit by a major surprise after an independent monitoring committee raised a warning after an imbalance in deaths in two on-going trials.
4. Reversal of type 1 diabetes possible through century-old vaccine
The American Diabetes Association 77th Scientific Sessions closed yesterday and one of the most interesting pieces of research to emerge was the work by Denise Faustman, alongside her team. They have been researching the potential for the BCG therapy to reverse advanced type 1 diabetes.
3. FDA calls for withdrawal of opioid product for first time in history
For the first time in the agency’s history, it has asked for the withdrawal of Endo Pharmaceutical’s opioid painkiller from the market due to the risk of abuse.
2. European Medicines Agency: Staying consistent in a turbulent time
With Brexit looming, the future of the EMA headquarters in London has been cast in doubt. Pharmafocus spoke to Marie-Agnes Heine, Head of the Communication Department, and Juan GarcÃa Burgos, Head of the Public Engagement Department, to discuss the medical communication role within the organisation and how the department is busier than ever.
1. Continuous Manufacturing: Novartis’ experiment in the future of drug production
Continuous manufacturing has long been touted as the future of drug production. Pharmafile approached Novartis for more details about its successes in the area, and the challenges, of developing the new process.
Related Content
Top Ten most popular articles on Pharmafile.com this week
As the year winds to a close, excitement is rising around the efficacy and availability …
Top Ten most popular articles on Pharmafile.com this week
The top ten news stories this week focus on herd immunity, as the Director of …
Pharmafile.com’s weekly COVID-19 news round-up
The coronavirus news this week focuses on the development of treatments to alleviate symptoms of …
